Shell Company. The Company is not, and was not in the past, an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act).
Appears in 13 contracts
Sources: Securities Purchase Agreement (Blue Ridge Bankshares, Inc.), Securities Purchase Agreement (Blue Ridge Bankshares, Inc.), Securities Purchase Agreement (Blue Ridge Bankshares, Inc.)
Shell Company. The Company is not, and was not in the past, an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act).
Appears in 6 contracts
Sources: Securities Purchase Agreement (Puma Biotechnology, Inc.), Stock Purchase Agreement (Alpine Immune Sciences, Inc.), Securities Purchase Agreement (Progenity, Inc.)
Shell Company. The Company is not, and was not in within the pastpast three (3) years, an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act).
Appears in 5 contracts
Sources: Securities Purchase Agreement (Rezolute, Inc.), Securities Purchase Agreement (Rezolute, Inc.), Securities Purchase Agreement (Rezolute, Inc.)
Shell Company. The Company is not, and was not in the pasthas never been, an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act).
Appears in 1 contract
Sources: Stock Purchase Agreement (Threshold Pharmaceuticals Inc)
Shell Company. The Company is not, and was not in the past, an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act).
Appears in 1 contract
Sources: Securities Purchase Agreement (Puma Biotechnology, Inc.)